SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5nva'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1C6Y_B_MK1B524_1 (PROTEIN (PROTEASE))	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 11	ALA A 392 ILE A 344 GLY A 385 ILE A 386 ILE A 159	None	0.93A	1c6yA-5nvaA: undetectable	1c6yA-5nvaA: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JU6_D_LYAD315_1 (THYMIDYLATE SYNTHASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 11	PHE A 150 ILE A 320 GLY A 330 TYR A 17 ALA A 338	None	1.50A	1ju6D-5nvaA: undetectable	1ju6D-5nvaA: 13.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KGL_A_RTLA175_0 (CELLULAR RETINOL-BINDING PROTEIN TYPE I)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	PHE A 222 LEU A 239 TYR A 83 GLY A 81 ILE A 79	None None None SLB A 503 (-3.7A) None	1.14A	1kglA-5nvaA: undetectable	1kglA-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NT2_A_SAMA301_0 (FIBRILLARIN-LIKE PRE-RRNA PROCESSING PROTEIN)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	GLY A 292 ALA A 71 THR A 215 SER A 66 ILE A 291	None	1.19A	1nt2A-5nvaA: undetectable	1nt2A-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NV8_A_SAMA300_0 (HEMK PROTEIN)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	ILE A 333 GLY A 330 GLY A 327 PHE A 337 ALA A 12	None	0.91A	1nv8A-5nvaA: undetectable	1nv8A-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NV8_B_SAMB301_0 (HEMK PROTEIN)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	ILE A 333 GLY A 330 GLY A 327 PHE A 337 ALA A 12	None	0.93A	1nv8B-5nvaA: undetectable	1nv8B-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SDV_B_MK1B902_1 (PROTEASE RETROPEPSIN)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 10	ALA A 392 ILE A 344 GLY A 385 ILE A 386 ILE A 159	None	0.91A	1sdvA-5nvaA: undetectable	1sdvA-5nvaA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T9W_A_NFNA6002_1 (ACRIFLAVINE RESISTANCE PROTEIN B)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	4 / 7	ALA A 35 ARG A 362 ASN A 356 GLU A 110	None	1.23A	1t9wA-5nvaA: undetectable	1t9wA-5nvaA: 5.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1VQ1_B_SAMB301_0 (N5-GLUTAMINE METHYLTRANSFERASE, HEMK)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	ILE A 333 GLY A 330 GLY A 327 PHE A 337 ALA A 12	None	0.81A	1vq1B-5nvaA: undetectable	1vq1B-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	MET A 151 LEU A 158 PHE A 15 GLN A 341 PHE A 337	None	1.49A	1xosA-5nvaA: undetectable	1xosA-5nvaA: 12.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AQU_B_DR7B300_2 (HIV-1 PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 11	ALA A 392 ILE A 344 GLY A 385 ILE A 386 ILE A 159	None	0.83A	2aquB-5nvaA: undetectable	2aquB-5nvaA: 21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NMY_A_ROCA401_1 (PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	ALA A 392 ILE A 344 GLY A 385 ILE A 386 ILE A 159	None	0.88A	2nmyA-5nvaA: undetectable	2nmyA-5nvaA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QBN_A_CAMA442_0 (CYTOCHROME P450-CAM)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	4 / 7	THR A 57 VAL A 178 VAL A 263 VAL A 45	NA A 502 ( 4.8A) NA A 502 (-4.2A) None None	0.96A	2qbnA-5nvaA: undetectable	2qbnA-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V0M_A_KLNA1500_1 (CYTOCHROME P450 3A4)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 11	PHE A 131 SER A 468 LEU A 456 ALA A 449 LEU A 413	None	1.33A	2v0mA-5nvaA: 0.0	2v0mA-5nvaA: 11.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V0M_B_KLNB1498_1 (CYTOCHROME P450 3A4)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 9	PHE A 131 SER A 468 LEU A 456 ALA A 449 LEU A 413	None	1.29A	2v0mB-5nvaA: undetectable	2v0mB-5nvaA: 11.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X2N_C_X2NC1479_1 (LANOSTEROL 14-ALPHA-DEMETHYLASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	PRO A 317 VAL A 321 ALA A 338 ALA A 340 THR A 140	None	1.28A	2x2nC-5nvaA: undetectable	2x2nC-5nvaA: 9.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XYT_B_TC9B1206_1 (SOLUBLE ACETYLCHOLINE RECEPTOR)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 11	THR A 170 TYR A 169 SER A 346 SER A 345 SER A 53	None None NA A 502 (-2.3A) NA A 502 (-2.3A) None	1.38A	2xytB-5nvaA: undetectable 2xytC-5nvaA: undetectable 2xytG-5nvaA: undetectable	2xytB-5nvaA: 17.89 2xytC-5nvaA: 17.89 2xytG-5nvaA: 17.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XZ5_D_ACHD1211_0 (SOLUBLE ACETYLCHOLINE RECEPTOR)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	4 / 8	THR A 140 GLN A 341 SER A 388 CYH A 166	None	1.12A	2xz5C-5nvaA: undetectable 2xz5D-5nvaA: undetectable	2xz5C-5nvaA: undetectable 2xz5D-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DEU_B_SALB306_1 (TRANSCRIPTIONAL REGULATOR SLYA)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	4 / 6	THR A 264 ILE A 179 SER A 53 THR A 273	None	0.92A	3deuB-5nvaA: undetectable	3deuB-5nvaA: 15.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKQ_A_ROCA100_1 (PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	ALA A 392 ILE A 344 GLY A 385 ILE A 386 ILE A 159	None	0.88A	3ekqA-5nvaA: undetectable	3ekqA-5nvaA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKW_B_DR7B100_1 (PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 10	ALA A 392 ILE A 344 GLY A 385 ILE A 386 ILE A 159	None	0.87A	3ekwA-5nvaA: undetectable	3ekwA-5nvaA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKX_B_1UNB201_2 (PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 11	ALA A 392 ILE A 344 GLY A 385 ILE A 386 ILE A 159	None	0.85A	3ekxB-5nvaA: undetectable	3ekxB-5nvaA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EM0_A_CHDA153_0 (ILEAL BILE ACID-BINDING PROTEIN)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	4 / 5	ILE A 88 THR A 419 PHE A 100 TYR A 96	None	1.34A	3em0A-5nvaA: undetectable	3em0A-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EM0_B_CHDB153_0 (ILEAL BILE ACID-BINDING PROTEIN)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	4 / 7	ILE A 464 PHE A 458 TYR A 461 GLY A 416	None	1.07A	3em0B-5nvaA: undetectable	3em0B-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3K4V_D_ROCD201_1 (HIV-1 PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	ALA A 392 ILE A 344 GLY A 385 ILE A 386 ILE A 159	None	0.80A	3k4vC-5nvaA: undetectable	3k4vC-5nvaA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDT_D_ROCD100_1 (PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	ALA A 392 ILE A 344 GLY A 385 ILE A 386 ILE A 159	None	0.80A	3ndtC-5nvaA: undetectable	3ndtC-5nvaA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDW_A_RITA100_2 (PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	6 / 9	ALA A 392 ILE A 344 GLY A 385 ILE A 386 VAL A 160 ILE A 159	None	1.27A	3ndwB-5nvaA: undetectable	3ndwB-5nvaA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDX_A_RITA100_2 (PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 11	ALA A 392 ILE A 344 GLY A 385 ILE A 386 ILE A 159	None	0.90A	3ndxB-5nvaA: undetectable	3ndxB-5nvaA: 20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NU4_B_478B401_1 (PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 9	ALA A 392 ILE A 162 GLY A 385 ILE A 386 ILE A 159	None	1.03A	3nu4A-5nvaA: undetectable	3nu4A-5nvaA: 19.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TEG_A_DAHA416_1 (PHENYLALANYL-TRNA SYNTHETASE, MITOCHONDRIAL)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	SER A 127 PHE A 123 GLY A 416 GLY A 420 GLY A 415	None	1.14A	3tegA-5nvaA: undetectable	3tegA-5nvaA: 12.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACA_B_DXCB1473_0 (TRANSLATION ELONGATION FACTOR SELB)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 9	ILE A 381 THR A 170 GLN A 32 GLY A 173 ARG A 44	None	1.40A	4acaB-5nvaA: undetectable 4acaC-5nvaA: undetectable	4acaB-5nvaA: undetectable 4acaC-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DQC_A_017A101_1 (ASPARTYL PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 10	ALA A 392 GLY A 385 ILE A 386 VAL A 160 ILE A 159	None	1.01A	4dqcA-5nvaA: undetectable	4dqcA-5nvaA: 19.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DTZ_B_LDPB501_1 (CYTOCHROME P450 BM3 VARIANT 8C8)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	4 / 6	ALA A 436 ALA A 477 PRO A 478 THR A 476	None	1.11A	4dtzB-5nvaA: undetectable	4dtzB-5nvaA: 10.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DX5_B_MIYB1103_1 (ACRIFLAVINE RESISTANCE PROTEIN B)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	GLY A 174 ASP A 182 ILE A 179 VAL A 45 ARG A 260	None NA A 502 (-2.1A) None None NA A 502 ( 4.5A)	1.12A	4dx5B-5nvaA: undetectable	4dx5B-5nvaA: 5.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EAH_F_ACTF402_0 (ACTIN, ALPHA SKELETAL MUSCLE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	3 / 3	PHE A 28 ASP A 37 ARG A 44	None	0.75A	4eahF-5nvaA: undetectable	4eahF-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EAH_G_ACTG401_0 (ACTIN, ALPHA SKELETAL MUSCLE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	3 / 3	PHE A 28 ASP A 37 ARG A 44	None	0.75A	4eahG-5nvaA: undetectable	4eahG-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J4V_A_SVRA301_1 (NUCLEOCAPSID PROTEIN)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 11	GLY A 465 ARG A 451 GLN A 249 MET A 418 PHE A 123	None	1.36A	4j4vA-5nvaA: undetectable	4j4vA-5nvaA: 15.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J4V_E_SVRE301_1 (NUCLEOCAPSID PROTEIN)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 10	GLY A 465 ARG A 451 GLN A 249 MET A 418 PHE A 123	None	1.32A	4j4vA-5nvaA: undetectable 4j4vE-5nvaA: 0.0	4j4vA-5nvaA: 15.92 4j4vE-5nvaA: 15.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KRH_A_SAMA900_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE 2)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	GLY A 412 GLY A 415 LEU A 130 SER A 127 HIS A 132	None	1.03A	4krhA-5nvaA: undetectable	4krhA-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KRH_B_SAMB900_0 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE 2)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	GLY A 412 GLY A 415 LEU A 130 SER A 127 HIS A 132	None	1.02A	4krhB-5nvaA: undetectable	4krhB-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NJT_D_017D101_1 (PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 11	ALA A 392 ILE A 344 GLY A 385 ILE A 386 ILE A 159	None	0.87A	4njtC-5nvaA: undetectable	4njtC-5nvaA: 23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U95_B_MIYB1102_1 (MULTIDRUG EFFLUX PUMP SUBUNIT ACRB)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 12	GLY A 174 ASP A 182 ILE A 179 VAL A 45 ARG A 260	None NA A 502 (-2.1A) None None NA A 502 ( 4.5A)	1.11A	4u95B-5nvaA: 1.7	4u95B-5nvaA: 5.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UUU_A_SAMA1546_0 (CYSTATHIONINE BETA-SYNTHASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 11	LEU A 239 PHE A 243 GLN A 82 THR A 63 ILE A 62	None SLB A 503 (-3.6A) SLB A 503 (-3.1A) SLB A 503 (-3.0A) SLB A 503 (-3.5A)	1.40A	4uuuA-5nvaA: undetectable 4uuuB-5nvaA: undetectable	4uuuA-5nvaA: undetectable 4uuuB-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EWU_A_BEZA1401_0 (MAGNESIUM-CHELATASE SUBUNIT CHLH, CHLOROPLASTIC)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	4 / 6	GLY A 51 THR A 273 SER A 53 VAL A 54	None	1.13A	5ewuA-5nvaA: undetectable	5ewuA-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5K50_A_ACTA1403_0 (L-THREONINE 3-DEHYDROGENASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	4 / 5	MET A 467 SER A 468 VAL A 469 GLY A 420	None	1.02A	5k50A-5nvaA: undetectable	5k50A-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L0Z_B_SAMB304_0 (PROBABLE RNA METHYLTRANSFERASE, TRMH FAMILY)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 10	GLY A 173 GLY A 177 ILE A 167 SER A 345 LEU A 348	None None None NA A 502 (-2.3A) None	0.90A	5l0zB-5nvaA: undetectable	5l0zB-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L0Z_B_SAMB304_0 (PROBABLE RNA METHYLTRANSFERASE, TRMH FAMILY)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 10	GLY A 174 GLY A 177 ILE A 167 SER A 345 LEU A 348	None None None NA A 502 (-2.3A) None	0.99A	5l0zB-5nvaA: undetectable	5l0zB-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L6E_B_ACTB401_0 (N6-ADENOSINE-METHYLT RANSFERASE 70 KDA SUBUNIT N6-ADENOSINE-METHYLT RANSFERASE SUBUNIT METTL14)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	4 / 6	GLU A 113 ARG A 121 LEU A 122 ARG A 362	None	0.98A	5l6eA-5nvaA: undetectable 5l6eB-5nvaA: undetectable	5l6eA-5nvaA: undetectable 5l6eB-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AY6_A_VORA501_1 (CYP51, STEROL 14ALPHA-DEMETHYLASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 9	TYR A 169 ALA A 338 ALA A 340 THR A 140 LEU A 161	None	1.49A	6ay6A-5nvaA: undetectable	6ay6A-5nvaA: 10.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DJ2_B_AB1B201_0 (HIV-1 PROTEASE)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 10	ALA A 392 ILE A 344 GLY A 385 ILE A 386 ILE A 159	None	0.97A	6dj2A-5nvaA: undetectable	6dj2A-5nvaA: 18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HU9_I_PCFI101_0 (CYTOCHROME B-C1 COMPLEX SUBUNIT 1, MITOCHONDRIAL CYTOCHROME B-C1 COMPLEX SUBUNIT 9 CYTOCHROME B-C1 COMPLEX SUBUNIT RIESKE, MITOCHONDRIAL)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 11	ASP A 358 SER A 357 VAL A 258 SER A 53 ALA A 49	None	1.03A	6hu9A-5nvaA: undetectable 6hu9E-5nvaA: undetectable 6hu9I-5nvaA: undetectable	6hu9A-5nvaA: undetectable 6hu9E-5nvaA: undetectable 6hu9I-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HU9_I_PCFI101_0 (CYTOCHROME B-C1 COMPLEX SUBUNIT 1, MITOCHONDRIAL CYTOCHROME B-C1 COMPLEX SUBUNIT 9 CYTOCHROME B-C1 COMPLEX SUBUNIT RIESKE, MITOCHONDRIAL)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 11	SER A 107 VAL A 380 GLY A 385 SER A 388 ALA A 391	None	1.38A	6hu9A-5nvaA: undetectable 6hu9E-5nvaA: undetectable 6hu9I-5nvaA: undetectable	6hu9A-5nvaA: undetectable 6hu9E-5nvaA: undetectable 6hu9I-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HU9_T_PCFT101_0 (CYTOCHROME B-C1 COMPLEX SUBUNIT 1, MITOCHONDRIAL CYTOCHROME B-C1 COMPLEX SUBUNIT 9 CYTOCHROME B-C1 COMPLEX SUBUNIT RIESKE, MITOCHONDRIAL)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 10	ASP A 358 SER A 357 VAL A 258 SER A 53 ALA A 49	None	1.07A	6hu9L-5nvaA: undetectable 6hu9P-5nvaA: undetectable 6hu9T-5nvaA: undetectable	6hu9L-5nvaA: undetectable 6hu9P-5nvaA: undetectable 6hu9T-5nvaA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HU9_T_PCFT101_0 (CYTOCHROME B-C1 COMPLEX SUBUNIT 1, MITOCHONDRIAL CYTOCHROME B-C1 COMPLEX SUBUNIT 9 CYTOCHROME B-C1 COMPLEX SUBUNIT RIESKE, MITOCHONDRIAL)	5nva	PUTATIVE SODIUM:SOLUTE SYMPORTER (Proteus mirabilis)	5 / 10	SER A 107 VAL A 380 GLY A 385 SER A 388 ALA A 391	None	1.40A	6hu9L-5nvaA: undetectable 6hu9P-5nvaA: undetectable 6hu9T-5nvaA: undetectable	6hu9L-5nvaA: undetectable 6hu9P-5nvaA: undetectable 6hu9T-5nvaA: undetectable

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1C6Y_B_MK1B524_1","PROTEIN (PROTEASE);PROTEIN (PROTEASE)","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;ILE A 159","None","0.93A","1c6yA-5nvaA:undetectable","1c6yA-5nvaA:21.10"],["1JU6_D_LYAD315_1","THYMIDYLATE SYNTHASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"PHE A 150;ILE A 320;GLY A 330;TYR A  17;ALA A 338","None","1.50A","1ju6D-5nvaA:undetectable","1ju6D-5nvaA:13.27"],["1KGL_A_RTLA175_0","CELLULAR RETINOL-BINDING PROTEIN TYPE I","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"PHE A 222;LEU A 239;TYR A  83;GLY A  81;ILE A  79","None;None;None;SLB A 503 (-3.7A);None","1.14A","1kglA-5nvaA:undetectable","1kglA-5nvaA:undetectable"],["1NT2_A_SAMA301_0","FIBRILLARIN-LIKE PRE-RRNA PROCESSING PROTEIN","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"GLY A 292;ALA A  71;THR A 215;SER A  66;ILE A 291","None","1.19A","1nt2A-5nvaA:undetectable","1nt2A-5nvaA:undetectable"],["1NV8_A_SAMA300_0","HEMK PROTEIN","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ILE A 333;GLY A 330;GLY A 327;PHE A 337;ALA A  12","None","0.91A","1nv8A-5nvaA:undetectable","1nv8A-5nvaA:undetectable"],["1NV8_B_SAMB301_0","HEMK PROTEIN","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ILE A 333;GLY A 330;GLY A 327;PHE A 337;ALA A  12","None","0.93A","1nv8B-5nvaA:undetectable","1nv8B-5nvaA:undetectable"],["1SDV_B_MK1B902_1","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;ILE A 159","None","0.91A","1sdvA-5nvaA:undetectable","1sdvA-5nvaA:20.20"],["1T9W_A_NFNA6002_1","ACRIFLAVINE RESISTANCE PROTEIN B","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",4,"ALA A  35;ARG A 362;ASN A 356;GLU A 110","None","1.23A","1t9wA-5nvaA:undetectable","1t9wA-5nvaA:5.85"],["1VQ1_B_SAMB301_0","N5-GLUTAMINE METHYLTRANSFERASE, HEMK","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ILE A 333;GLY A 330;GLY A 327;PHE A 337;ALA A  12","None","0.81A","1vq1B-5nvaA:undetectable","1vq1B-5nvaA:undetectable"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"MET A 151;LEU A 158;PHE A  15;GLN A 341;PHE A 337","None","1.49A","1xosA-5nvaA:undetectable","1xosA-5nvaA:12.11"],["2AQU_B_DR7B300_2","HIV-1 PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;ILE A 159","None","0.83A","2aquB-5nvaA:undetectable","2aquB-5nvaA:21.15"],["2NMY_A_ROCA401_1","PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;ILE A 159","None","0.88A","2nmyA-5nvaA:undetectable","2nmyA-5nvaA:20.20"],["2QBN_A_CAMA442_0","CYTOCHROME P450-CAM","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",4,"THR A  57;VAL A 178;VAL A 263;VAL A  45"," NA A 502 ( 4.8A); NA A 502 (-4.2A);None;None","0.96A","2qbnA-5nvaA:undetectable","2qbnA-5nvaA:undetectable"],["2V0M_A_KLNA1500_1","CYTOCHROME P450 3A4","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"PHE A 131;SER A 468;LEU A 456;ALA A 449;LEU A 413","None","1.33A","2v0mA-5nvaA:0.0","2v0mA-5nvaA:11.74"],["2V0M_B_KLNB1498_1","CYTOCHROME P450 3A4","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"PHE A 131;SER A 468;LEU A 456;ALA A 449;LEU A 413","None","1.29A","2v0mB-5nvaA:undetectable","2v0mB-5nvaA:11.74"],["2X2N_C_X2NC1479_1","LANOSTEROL 14-ALPHA-DEMETHYLASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"PRO A 317;VAL A 321;ALA A 338;ALA A 340;THR A 140","None","1.28A","2x2nC-5nvaA:undetectable","2x2nC-5nvaA:9.05"],["2XYT_B_TC9B1206_1","SOLUBLE ACETYLCHOLINE RECEPTOR;SOLUBLE ACETYLCHOLINE RECEPTOR;SOLUBLE ACETYLCHOLINE RECEPTOR","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"THR A 170;TYR A 169;SER A 346;SER A 345;SER A  53","None;None; NA A 502 (-2.3A); NA A 502 (-2.3A);None","1.38A","2xytB-5nvaA:undetectable;2xytC-5nvaA:undetectable;2xytG-5nvaA:undetectable","2xytB-5nvaA:17.89;2xytC-5nvaA:17.89;2xytG-5nvaA:17.89"],["2XZ5_D_ACHD1211_0","SOLUBLE ACETYLCHOLINE RECEPTOR","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",4,"THR A 140;GLN A 341;SER A 388;CYH A 166","None","1.12A","2xz5C-5nvaA:undetectable;2xz5D-5nvaA:undetectable","2xz5C-5nvaA:undetectable;2xz5D-5nvaA:undetectable"],["3DEU_B_SALB306_1","TRANSCRIPTIONAL REGULATOR SLYA","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",4,"THR A 264;ILE A 179;SER A  53;THR A 273","None","0.92A","3deuB-5nvaA:undetectable","3deuB-5nvaA:15.48"],["3EKQ_A_ROCA100_1","PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;ILE A 159","None","0.88A","3ekqA-5nvaA:undetectable","3ekqA-5nvaA:20.20"],["3EKW_B_DR7B100_1","PROTEASE;PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;ILE A 159","None","0.87A","3ekwA-5nvaA:undetectable","3ekwA-5nvaA:20.20"],["3EKX_B_1UNB201_2","PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;ILE A 159","None","0.85A","3ekxB-5nvaA:undetectable","3ekxB-5nvaA:20.20"],["3EM0_A_CHDA153_0","ILEAL BILE ACID-BINDING PROTEIN","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",4,"ILE A  88;THR A 419;PHE A 100;TYR A  96","None","1.34A","3em0A-5nvaA:undetectable","3em0A-5nvaA:undetectable"],["3EM0_B_CHDB153_0","ILEAL BILE ACID-BINDING PROTEIN","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",4,"ILE A 464;PHE A 458;TYR A 461;GLY A 416","None","1.07A","3em0B-5nvaA:undetectable","3em0B-5nvaA:undetectable"],["3K4V_D_ROCD201_1","HIV-1 PROTEASE;HIV-1 PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;ILE A 159","None","0.80A","3k4vC-5nvaA:undetectable","3k4vC-5nvaA:20.20"],["3NDT_D_ROCD100_1","PROTEASE;PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;ILE A 159","None","0.80A","3ndtC-5nvaA:undetectable","3ndtC-5nvaA:20.00"],["3NDW_A_RITA100_2","PROTEASE;PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",6,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;VAL A 160;ILE A 159","None","1.27A","3ndwB-5nvaA:undetectable","3ndwB-5nvaA:20.20"],["3NDX_A_RITA100_2","PROTEASE;PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;ILE A 159","None","0.90A","3ndxB-5nvaA:undetectable","3ndxB-5nvaA:20.20"],["3NU4_B_478B401_1","PROTEASE;PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 162;GLY A 385;ILE A 386;ILE A 159","None","1.03A","3nu4A-5nvaA:undetectable","3nu4A-5nvaA:19.27"],["3TEG_A_DAHA416_1","PHENYLALANYL-TRNA SYNTHETASE, MITOCHONDRIAL","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"SER A 127;PHE A 123;GLY A 416;GLY A 420;GLY A 415","None","1.14A","3tegA-5nvaA:undetectable","3tegA-5nvaA:12.85"],["4ACA_B_DXCB1473_0","TRANSLATION ELONGATION FACTOR SELB","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ILE A 381;THR A 170;GLN A  32;GLY A 173;ARG A  44","None","1.40A","4acaB-5nvaA:undetectable;4acaC-5nvaA:undetectable","4acaB-5nvaA:undetectable;4acaC-5nvaA:undetectable"],["4DQC_A_017A101_1","ASPARTYL PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;GLY A 385;ILE A 386;VAL A 160;ILE A 159","None","1.01A","4dqcA-5nvaA:undetectable","4dqcA-5nvaA:19.19"],["4DTZ_B_LDPB501_1","CYTOCHROME P450 BM3 VARIANT 8C8","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",4,"ALA A 436;ALA A 477;PRO A 478;THR A 476","None","1.11A","4dtzB-5nvaA:undetectable","4dtzB-5nvaA:10.39"],["4DX5_B_MIYB1103_1","ACRIFLAVINE RESISTANCE PROTEIN B","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"GLY A 174;ASP A 182;ILE A 179;VAL A  45;ARG A 260","None; NA A 502 (-2.1A);None;None; NA A 502 ( 4.5A)","1.12A","4dx5B-5nvaA:undetectable","4dx5B-5nvaA:5.85"],["4EAH_F_ACTF402_0","ACTIN, ALPHA SKELETAL MUSCLE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",3,"PHE A  28;ASP A  37;ARG A  44","None","0.75A","4eahF-5nvaA:undetectable","4eahF-5nvaA:undetectable"],["4EAH_G_ACTG401_0","ACTIN, ALPHA SKELETAL MUSCLE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",3,"PHE A  28;ASP A  37;ARG A  44","None","0.75A","4eahG-5nvaA:undetectable","4eahG-5nvaA:undetectable"],["4J4V_A_SVRA301_1","NUCLEOCAPSID PROTEIN","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"GLY A 465;ARG A 451;GLN A 249;MET A 418;PHE A 123","None","1.36A","4j4vA-5nvaA:undetectable","4j4vA-5nvaA:15.92"],["4J4V_E_SVRE301_1","NUCLEOCAPSID PROTEIN;NUCLEOCAPSID PROTEIN","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"GLY A 465;ARG A 451;GLN A 249;MET A 418;PHE A 123","None","1.32A","4j4vA-5nvaA:undetectable;4j4vE-5nvaA:0.0","4j4vA-5nvaA:15.92;4j4vE-5nvaA:15.92"],["4KRH_A_SAMA900_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE 2","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"GLY A 412;GLY A 415;LEU A 130;SER A 127;HIS A 132","None","1.03A","4krhA-5nvaA:undetectable","4krhA-5nvaA:undetectable"],["4KRH_B_SAMB900_0","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE 2","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"GLY A 412;GLY A 415;LEU A 130;SER A 127;HIS A 132","None","1.02A","4krhB-5nvaA:undetectable","4krhB-5nvaA:undetectable"],["4NJT_D_017D101_1","PROTEASE;PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;ILE A 159","None","0.87A","4njtC-5nvaA:undetectable","4njtC-5nvaA:23.08"],["4U95_B_MIYB1102_1","MULTIDRUG EFFLUX PUMP SUBUNIT ACRB","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"GLY A 174;ASP A 182;ILE A 179;VAL A  45;ARG A 260","None; NA A 502 (-2.1A);None;None; NA A 502 ( 4.5A)","1.11A","4u95B-5nvaA:1.7","4u95B-5nvaA:5.75"],["4UUU_A_SAMA1546_0","CYSTATHIONINE BETA-SYNTHASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"LEU A 239;PHE A 243;GLN A  82;THR A  63;ILE A  62","None;SLB A 503 (-3.6A);SLB A 503 (-3.1A);SLB A 503 (-3.0A);SLB A 503 (-3.5A)","1.40A","4uuuA-5nvaA:undetectable;4uuuB-5nvaA:undetectable","4uuuA-5nvaA:undetectable;4uuuB-5nvaA:undetectable"],["5EWU_A_BEZA1401_0","MAGNESIUM-CHELATASE SUBUNIT CHLH, CHLOROPLASTIC","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",4,"GLY A  51;THR A 273;SER A  53;VAL A  54","None","1.13A","5ewuA-5nvaA:undetectable","5ewuA-5nvaA:undetectable"],["5K50_A_ACTA1403_0","L-THREONINE 3-DEHYDROGENASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",4,"MET A 467;SER A 468;VAL A 469;GLY A 420","None","1.02A","5k50A-5nvaA:undetectable","5k50A-5nvaA:undetectable"],["5L0Z_B_SAMB304_0","PROBABLE RNA METHYLTRANSFERASE, TRMH FAMILY","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"GLY A 173;GLY A 177;ILE A 167;SER A 345;LEU A 348","None;None;None; NA A 502 (-2.3A);None","0.90A","5l0zB-5nvaA:undetectable","5l0zB-5nvaA:undetectable"],["5L0Z_B_SAMB304_0","PROBABLE RNA METHYLTRANSFERASE, TRMH FAMILY","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"GLY A 174;GLY A 177;ILE A 167;SER A 345;LEU A 348","None;None;None; NA A 502 (-2.3A);None","0.99A","5l0zB-5nvaA:undetectable","5l0zB-5nvaA:undetectable"],["5L6E_B_ACTB401_0","N6-ADENOSINE-METHYLTRANSFERASE 70 KDA SUBUNIT;N6-ADENOSINE-METHYLTRANSFERASE SUBUNIT METTL14","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",4,"GLU A 113;ARG A 121;LEU A 122;ARG A 362","None","0.98A","5l6eA-5nvaA:undetectable;5l6eB-5nvaA:undetectable","5l6eA-5nvaA:undetectable;5l6eB-5nvaA:undetectable"],["6AY6_A_VORA501_1","CYP51, STEROL 14ALPHA-DEMETHYLASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"TYR A 169;ALA A 338;ALA A 340;THR A 140;LEU A 161","None","1.49A","6ay6A-5nvaA:undetectable","6ay6A-5nvaA:10.24"],["6DJ2_B_AB1B201_0","HIV-1 PROTEASE","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ALA A 392;ILE A 344;GLY A 385;ILE A 386;ILE A 159","None","0.97A","6dj2A-5nvaA:undetectable","6dj2A-5nvaA:18.18"],["6HU9_I_PCFI101_0","CYTOCHROME B-C1 COMPLEX SUBUNIT 1, MITOCHONDRIAL;CYTOCHROME B-C1 COMPLEX SUBUNIT 9;CYTOCHROME B-C1 COMPLEX SUBUNIT RIESKE, MITOCHONDRIAL","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ASP A 358;SER A 357;VAL A 258;SER A  53;ALA A  49","None","1.03A","6hu9A-5nvaA:undetectable;6hu9E-5nvaA:undetectable;6hu9I-5nvaA:undetectable","6hu9A-5nvaA:undetectable;6hu9E-5nvaA:undetectable;6hu9I-5nvaA:undetectable"],["6HU9_I_PCFI101_0","CYTOCHROME B-C1 COMPLEX SUBUNIT 1, MITOCHONDRIAL;CYTOCHROME B-C1 COMPLEX SUBUNIT 9;CYTOCHROME B-C1 COMPLEX SUBUNIT RIESKE, MITOCHONDRIAL","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"SER A 107;VAL A 380;GLY A 385;SER A 388;ALA A 391","None","1.38A","6hu9A-5nvaA:undetectable;6hu9E-5nvaA:undetectable;6hu9I-5nvaA:undetectable","6hu9A-5nvaA:undetectable;6hu9E-5nvaA:undetectable;6hu9I-5nvaA:undetectable"],["6HU9_T_PCFT101_0","CYTOCHROME B-C1 COMPLEX SUBUNIT 1, MITOCHONDRIAL;CYTOCHROME B-C1 COMPLEX SUBUNIT 9;CYTOCHROME B-C1 COMPLEX SUBUNIT RIESKE, MITOCHONDRIAL","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"ASP A 358;SER A 357;VAL A 258;SER A  53;ALA A  49","None","1.07A","6hu9L-5nvaA:undetectable;6hu9P-5nvaA:undetectable;6hu9T-5nvaA:undetectable","6hu9L-5nvaA:undetectable;6hu9P-5nvaA:undetectable;6hu9T-5nvaA:undetectable"],["6HU9_T_PCFT101_0","CYTOCHROME B-C1 COMPLEX SUBUNIT 1, MITOCHONDRIAL;CYTOCHROME B-C1 COMPLEX SUBUNIT 9;CYTOCHROME B-C1 COMPLEX SUBUNIT RIESKE, MITOCHONDRIAL","5nva","PUTATIVE SODIUM:SOLUTE SYMPORTER","Proteus mirabilis",5,"SER A 107;VAL A 380;GLY A 385;SER A 388;ALA A 391","None","1.40A","6hu9L-5nvaA:undetectable;6hu9P-5nvaA:undetectable;6hu9T-5nvaA:undetectable","6hu9L-5nvaA:undetectable;6hu9P-5nvaA:undetectable;6hu9T-5nvaA:undetectable"]]